Paediatric pulmonary echinococcosis: A neglected disease

Pierre Goussard1, Ernst Eber2, Lunga Mfingwana1

  • 1Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg Hospital, Cape Town, South Africa.

Insights

Cystic echinococcosis (CE) primarily affects the lungs in children, unlike adults. Diagnosis requires imaging, serology, and histology, especially in high-burden infectious disease areas.

Area of Science:

  • Parasitology
  • Pediatric Medicine
  • Radiology

Background:

  • Echinococcosis is a global health concern, particularly impacting children in endemic regions.
  • Cystic echinococcosis (CE) presents differently in children versus adults, with pulmonary involvement being predominant in pediatric cases.
  • Pulmonary cysts in children are often discovered incidentally on chest X-rays or due to complications like rupture or infection.

Purpose of the Study:

  • To highlight the unique presentation and diagnostic challenges of pulmonary cystic echinococcosis in children.
  • To emphasize the importance of a multidisciplinary diagnostic approach for pediatric pulmonary CE.
  • To discuss the management strategies for pulmonary CE in the pediatric population.

Main Methods:

  • Review of clinical presentations and diagnostic modalities for pulmonary cystic echinococcosis in pediatric patients.
  • Analysis of differential diagnoses for pulmonary cysts in children, considering co-endemic infections like AIDS and TB.
  • Evaluation of treatment outcomes combining surgery and chemotherapy.

Main Results:

  • Pulmonary involvement is the most common manifestation of CE in children, contrasting with hepatic predominance in adults.
  • Diagnosing pulmonary CE in children necessitates integrating imaging, serological tests, and histological findings.
  • Diagnostic complexity is increased in regions with high burdens of other infectious diseases, requiring consideration of atypical presentations.

Conclusions:

  • Pulmonary cystic echinococcosis is a significant pediatric health issue in endemic areas.
  • Accurate diagnosis of pediatric pulmonary CE relies on a comprehensive approach combining various diagnostic tools.
  • Effective management involves a combination of surgical intervention and antiparasitic chemotherapy.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
934
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
605
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
502
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
388
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
263